$JBLU

Sharma Vivek sold $143K of JBLU

Sharma Vivek sold 26,415 shares of JETBLUE AIRWAYS CORP (JBLU) at $5.41 ($0.14M total) on 2026-05-28.

Original reporting
SEC EDGAR · Sharma Vivek
Published Jun 1, 2026, 10:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 1, 2026, 10:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$JBLU
Neutral
medium confidence
Mentioned
$JBLU
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JBLUNeutralLow
01

Why it matters

This provides a new datapoint on insider behavior but does not, by itself, change JetBlue’s operating outlook.

02

Market read

Traders may briefly reassess sentiment/risk around JBLU, but the filing alone is unlikely to drive a major repricing without accompanying fundamental catalysts.

03

What to watch

Compare this sale size to prior insider transactions and the director’s typical selling cadence; also check for any concurrent news (financing, guidance, labor, aircraft issues) not present in this filing.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed June 1 (covers sale dated May 28)

Background

The article is an SEC EDGAR Form 4 disclosure of an insider’s open-market sale by a director of JetBlue Airways.

Company-level read

Ticker impact

$JBLUNeutralMedium confidence
Context

Director Sharma Vivek sold 26,415 shares in an open-market transaction disclosed via SEC Form 4 on May 28.

Expected impact

Likely small, short-lived pressure or no sustained move unless accompanied by broader company-specific catalysts.

Evidence & confidence

The filing is a disclosed ownership change (not earnings/guidance/M&A). Without additional context (e.g., size vs. typical activity, stated reasons), the tradable impact is usually limited.

Market effects

Could marginally affect airline/leveraged travel sentiment if investors treat insider selling as risk-raising, but no sector-wide catalyst is indicated.

No clear regional spillover beyond US-listed airline sentiment.

Limited; this is company-specific insider activity with no stated global event.

Counterpoint

The sale may be routine liquidity/portfolio rebalancing; absence of a stated 10b5-1 plan doesn’t automatically imply negative fundamentals.

Key entities

  • JetBlue Airways Corp

    US-listed airline whose director disclosed an open-market sale of shares via SEC Form 4.

  • Sharma Vivek

    Director who sold 26,415 shares at $5.41/share (total ~$142.9K).

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$JBLUMedAI 8/10

JetBlue raises third-quarter fuel price forecast

JetBlue Airways raised its third-quarter fuel price forecast to $3.96 per gallon, up from $3.49, due to elevated prices from the Iran war. The airline also reported higher operating costs from weather and air traffic disruptions. Despite these, it expects revenue per available seat mile to rise 17-20%, up from prior guidance of 12.5-16.5%. Shares were down 1% in premarket trading.

$JBLUHighAI 8/10

Why is JetBlue Airways stock climbing today?

JetBlue Airways (JBLU) stock rose 0.7% in pre-market trading after revising its Q3 2026 revenue guidance upwards to 17-20% YoY growth, up from 12.5-16.5%. The company also tightened its capacity outlook but increased its cost forecast due to weather disruptions. The move reflects company-specific optimism rather than broader market trends.

$JBLUHigh

JetBlue stock falls 3% despite raising revenue outlook

JetBlue (JBLU) shares fell 3% after raising its Q3 2026 revenue outlook to 17.0%-20.0% YoY growth, up from 12.5%-16.5%. Higher costs, including fuel and operational disruptions, offset the improved outlook, with CASM ex-Fuel expected to rise 6.0%-8.0% YoY. The airline also reduced its capacity growth outlook and lowered capital expenditures guidance to $275M.

$LUNRMed

Stocks making the biggest moves midday: EyePoint, Intuitive Machines, Workday, JetBlue & more

Midday movers included Intuitive Machines, up about 9% after saying it received an authorization to proceed for a $600 million multisatellite communications program. EyePoint Pharmaceuticals fell about 70% after its Phase 3 wet AMD treatment failed its primary goal. JetBlue dropped 6% after a Seaport Research downgrade. Onto Innovation rose on Goldman coverage. Workday fell after a Deutsche Bank downgrade. Memory chip stocks rose after comments on Apple buying Chinese chips.